(Reuters) -Indian shares gave up opening gains to inch lower on Friday, as worries over moderation in corporate earnings ...

Dr. Reddy's stock falls on Q3 fiscal 2025 results, wherein earnings match estimates but revenues beat the same.

Dr Reddy’s Laboratories share price declined more than 6% in the morning trades on Friday post Q3 results that were announced after the market hours of Thursday ...

Donald Trump's swearing-in ceremony, Davos and Q3 earnings are among the major events that took place this week.

Dr Reddy’s Laboratories on Thursday said its consolidated net profit increased 2 per cent to Rs 1,413 crore in the third ...

Shares of Dr Reddy’s Laboratories on Friday ended 5 per cent lower after the company's third-quarter earnings failed to cheer ...

Shares of Dr Reddy's Laboratories fell by 5% as the company's third-quarter profit rise failed to impress investors. The ...

Retail and banking stocks rose 0.5 per cent and 0.7 per cent, respectively. NEW DELHI: Vodafone Idea(numbers of share traded: ...

The Nifty 50 fell 0.49% to 23,092.2 on the day, while the BSE Sensex shed 0.43% to 76,190.46. Both indexes swung between ...

The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

The second wave of Covid-19 is ebbing in India with total active cases at less than 20 per cent of May highs. NEW DELHI: ...